Company Data

MeiraGTx Holdings plc

Ticker
MGTX
Current Price
$5.255 3.04%
Market Cap
$422.3M
Price Target
Refer to Report
Volume
175.1K
52wk Range
$3.85 - $8.75
Advanced Market Data

Overview

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company’s pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and European Union.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy